drugset / Trial / NCT06993181
Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare pharmacokinetics and safety profiles of DA-5222 single-administration and co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in healthy adult subjects
Timeline
- Start
- 2025-06
- Primary completion
- 2025-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5222 | Unknown | — | — |
| Subject | DA-5222-R1 | Unknown | — | — |
| Subject | DA-5222-R2 | Unknown | — | — |
| Subject | DA-5222-R3 | Unknown | — | — |
Indications
No indication recorded.